Your session is about to expire
← Back to Search
Treatment for Brain Aneurysm (CAFI Trial)
CAFI Trial Summary
This trial will enroll up to 150 patients at up to 30 sites in the United States.
- Brain Aneurysm
CAFI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCAFI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- You have had a heart attack, stroke, or mini-stroke (also known as TIA) within the past 6 months.You have had brain surgery, radiation treatment in the area where the device would be implanted, or a recent head injury that would prevent the device from being implanted.You have a burst blood vessel in your brain called an aneurysm.You have a medical condition that could make the aneurysm embolization procedure too risky for you.You have other medical conditions that make it difficult for you to follow the study requirements, or that could increase the risk of certain procedures or death within the next 2 years. These conditions may include liver failure, cancer, heart failure, chronic lung disease, weak immune system, nerve problems, or blood disorders.Your body or health condition is not suitable for a certain type of treatment called endovascular treatment.You are allergic to platinum, nickel, or titanium.You are allergic to substances used for imaging tests.You cannot take blood thinners or medications that prevent blood platelets from sticking together.You are eligible for a non-emergency procedure called endovascular embolization to treat a specific type of brain aneurysm called saccular IAs.You have an aneurysm located at a specific point in your blood vessels that is too large to be treated with the available device.You have other devices or implants in your body that could stop the Neqstent from fully expanding.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still available openings for participation in this experiment?
"According to the clinicaltrials.gov database, this protocol has not been actively recruiting since January 25th 2022 and is no longer seeking participants. Nonetheless, there are 153 other medical trials presently in need of volunteers."
Are there any specific criteria for joining this experiment?
"This trial is searching for 38 participants that are diagnosed with berry aneurysm between the ages of 18-80. To be considered, applicants must have adequate cognitive faculties to agree and abide by the study parameters, in addition to being ideal candidates for non-emergency endovascular embolization."
Can those over the age of sixty partake in this research?
"Qualified enrollees must be between 18 and 80 years of age. Those under the legal age for consent can participate in 7 trials, while individuals older than 65 may enter 151 separate studies."
Share this study with friends
Copy Link
Messenger